DiaMedica diamedica.com


Public lists: Pharma Startups (6570)

DiaMedica is a clinical stage biopharmaceutical company primarily focused on the development of recombinant (synthetic) proteins and commercialization of recombinant proteins to treat neurological and kidney diseases.

DiaMedica is a clinical stage biopharmaceutical company primarily focused on the development of recombinant (synthetic) proteins and commercialization of recombinant proteins to treat neurological and kidney diseases.

Company (IPO / Went public)

Phone: 763-496-5454

Fax:

2 Carlson Parkway

Minneapolis, 55447
Minnesota, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
DiaMedica $16.4M Dec 6, 2018
Biodel $80.1M Feb 18, 2008
Poniard Pharmaceuticals $99.1M Apr 18, 2006
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related DiaMedica Jobs

jobs by Indeed job
						search

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Human tissue kallikrein 1 glycosylation isoforms May 12, 2016 Dec 12, 2017 Patent
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods Jun 11, 2015 Apr 11, 2017 Patent
Human tissue kallikrein 1 glycosylation isoforms Apr 02, 2015 Jun 14, 2016 Patent
Use of drug combinations for treating insulin resistance May 20, 2005 Mar 18, 2014 Patent
Tissue kallikrein for the treatment of diseases associated with amyloid protein Jul 18, 2008 Aug 06, 2013 Patent
See all 9 patents